FIG. 3.

VergenixFG treatment results with high initial inflammation in rat wounds. Full-thickness cutaneous wounds were created on rats backs and treated with rhCollagen flowable gel, saline control, bovine collagen flowable matrix commercial control (Control 1), or human collagen gel commercial control (Control 2). Microscopical wound inflammation was assessed and scored on days 1, 3, and 6, based on H&E-stained slides. Human collagen Control (control) was not available for day-1 analysis (n=3) (*p<0.05).